WallStreetZenWallStreetZen

NASDAQ: ACST
Acasti Pharma Inc Stock

$2.62-0.01 (-0.38%)
Updated May 29, 2024
ACST Price
$2.62
Fair Value Price
$2.69
Market Cap
$24.64M
52 Week Low
$1.72
52 Week High
$3.84
P/E
-0.52x
P/B
0.38x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$38.77M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.18
Operating Cash Flow
-$14M
Beta
0.9
Next Earnings
Jun 21, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ACST Overview

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACST scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACST ($2.62) is undervalued by 2.53% relative to our estimate of its Fair Value price of $2.69 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ACST ($2.62) is not significantly undervalued (2.53%) relative to our estimate of its Fair Value price of $2.69 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ACST is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ACST due diligence checks available for Premium users.

Be the first to know about important ACST news, forecast changes, insider trades & much more!

ACST News

Valuation

ACST fair value

Fair Value of ACST stock based on Discounted Cash Flow (DCF)
Price
$2.62
Fair Value
$2.69
Undervalued by
2.57%
ACST ($2.62) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ACST ($2.62) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ACST is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACST price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.52x
Industry
15.85x
Market
31x

ACST price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.38x
Industry
5.94x
ACST is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACST's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.4M
Profit Margin
0%
ACST's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$76.2M
Liabilities
$11.5M
Debt to equity
0.18
ACST's short-term assets ($26.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACST's short-term assets ($26.88M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACST's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ACST's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.9M
Investing
-$6.6M
Financing
$0.0
ACST's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACST vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ACST$24.64M-0.34%-0.52x0.38x
BCTX$24.61M+12.41%-1.93x-3.05x
PHGE$24.43M-2.78%-0.57x-2.56x
ENLV$24.36M-5.07%-0.84x0.81x
APM$25.00M-1.93%-7.78x1.01x

Acasti Pharma Stock FAQ

What is Acasti Pharma's quote symbol?

(NASDAQ: ACST) Acasti Pharma trades on the NASDAQ under the ticker symbol ACST. Acasti Pharma stock quotes can also be displayed as NASDAQ: ACST.

If you're new to stock investing, here's how to buy Acasti Pharma stock.

What is the 52 week high and low for Acasti Pharma (NASDAQ: ACST)?

(NASDAQ: ACST) Acasti Pharma's 52-week high was $3.84, and its 52-week low was $1.72. It is currently -31.74% from its 52-week high and 52.38% from its 52-week low.

How much is Acasti Pharma stock worth today?

(NASDAQ: ACST) Acasti Pharma currently has 9,399,404 outstanding shares. With Acasti Pharma stock trading at $2.62 per share, the total value of Acasti Pharma stock (market capitalization) is $24.64M.

Acasti Pharma stock was originally listed at a price of $12.10 in Feb 7, 2012. If you had invested in Acasti Pharma stock at $12.10, your return over the last 12 years would have been -78.34%, for an annualized return of -11.97% (not including any dividends or dividend reinvestments).

How much is Acasti Pharma's stock price per share?

(NASDAQ: ACST) Acasti Pharma stock price per share is $2.62 today (as of May 29, 2024).

What is Acasti Pharma's Market Cap?

(NASDAQ: ACST) Acasti Pharma's market cap is $24.64M, as of May 30, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Acasti Pharma's market cap is calculated by multiplying ACST's current stock price of $2.62 by ACST's total outstanding shares of 9,399,404.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.